
Sign up to save your podcasts
Or


A $30 million dollar, phase 3 clinical trial is about to begin at Northwestern, investigating whether exercise can slow Parkinson's disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences is leading the trial and explains what he hopes to accomplish.
By Northwestern University Feinberg School of Medicine4.9
2424 ratings
A $30 million dollar, phase 3 clinical trial is about to begin at Northwestern, investigating whether exercise can slow Parkinson's disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences is leading the trial and explains what he hopes to accomplish.

91,051 Listeners

21,944 Listeners

43,592 Listeners

91 Listeners

6,469 Listeners

112,275 Listeners

5 Listeners

56,589 Listeners

0 Listeners

10,276 Listeners

33 Listeners

3,037 Listeners

8,213 Listeners

29,305 Listeners

1,587 Listeners

4,300 Listeners

7 Listeners

631 Listeners

12,388 Listeners